Gabapentin reduces nausea caused by GLP-1 drugs in both FDA database analysis and mouse experiments | Research

The takeaway

FDA adverse event database analysis identified gabapentin as significantly reducing GLP-1RA-induced nausea, confirmed by mouse experiments showing gabapentin decreased exenatide-induced pica behavior.

Gabapentin reduces GLP-1 nausea
Both FDA adverse event data and mouse experiments confirm gabapentin significantly reduces nausea from GLP-1 receptor agonists

What the researchers found

FAERS analysis: gabapentin and acetaminophen significantly lowered nausea events in GLP-1-treated patients. Mouse validation: exenatide induced dose-dependent pica (nausea); gabapentin co-treatment significantly decreased exenatide-induced pica without affecting food intake.

Why it matters

Nausea is the #1 reason patients discontinue GLP-1 drugs. Finding an effective co-medication like gabapentin could dramatically improve adherence and allow more patients to benefit from these transformative drugs.

How the study worked

Retrospective analysis of FDA AERS database for drug combinations reducing GLP-1-associated nausea. In vivo validation using exenatide-induced pica behavior in mice with gabapentin co-administration.

What this study cannot tell us

FAERS data is observational and subject to reporting biases. Mouse pica is a proxy for nausea, not direct measurement. Only gabapentin validated in vivo; acetaminophen needs confirmation. Only exenatide tested in mice.

How to read the evidence

Novel pharmacoepidemiological approach (FAERS mining) with preclinical validation. Hypothesis-generating with strong rationale but needs clinical trial confirmation.

When this study was published

Published in 2025.

The bigger picture

As GLP-1 drugs are prescribed to millions, managing their GI side effects becomes a major clinical priority. Repurposing existing medications like gabapentin could solve this problem faster than developing new anti-nausea agents.

Questions still open

Would gabapentin reduce nausea from semaglutide and tirzepatide in clinical trials?
What is the mechanism by which gabapentin reduces GLP-1 drug nausea?
Could prophylactic gabapentin improve GLP-1 drug adherence?

Common questions

Why do GLP-1 drugs cause nausea?

GLP-1 drugs slow stomach emptying and act on nausea centers in the brain. This causes the most common side effect—nausea and vomiting—which is a leading reason people stop taking these otherwise very effective weight loss and diabetes medications.

Could gabapentin help with GLP-1 drug nausea?

This study found strong evidence that it could. Both real-world prescription data from the FDA and controlled animal experiments showed gabapentin significantly reduced nausea from GLP-1 drugs. Clinical trials are needed to confirm this, but gabapentin is already a well-known and widely available medication.

Read the original research

In Silico Exploration of Therapeutics for GLP-1 Receptor Agonist-Induced Nausea and Their in Vivo Validation in Mice.

Biological & pharmaceutical bulletin, 48(8), 1233-1238

View on PubMed ↗Publisher’s paper ↗

Citation

Shibui, Norihiro; Suzuki, Takahide; Yamamoto, Hiroki; Shirakawa, Hisashi; Kaneko, Shuji; Yamamoto, Kouichi; Nagayasu, Kazuki. (2025). In Silico Exploration of Therapeutics for GLP-1 Receptor Agonist-Induced Nausea and Their in Vivo Validation in Mice.. Biological & pharmaceutical bulletin, 48(8), 1233-1238. https://doi.org/10.1248/bpb.b25-00077